Document Detail


Better assessment of nodal metastases by PET/CT fusion compared to side-by-side PET/CT in oesophageal cancer.
MedLine Citation:
PMID:  18630473     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Recently, positron emission tomography/computed tomography (PET/CT) has been introduced in the staging of oesophageal cancer. The impact of PET/CT fusion in comparison with side-by-side PET/CT in these tumours, was analyzed. PATIENTS AND METHODS: In 61 patients, 18-F-fluorodeoxyglucose (FDG)-PET and multidetector (md)-CT were performed within a two week interval. Software-fusion of md-CT and FDG-PET was correlated with side-by-side FDG-PET/CT reading by two independent investigators. The gold standard was the pathological outcome or clinical evidence of progression during the first year of follow-up. RESULTS: In 18 patients (18/61; 30%), nodal staging improved with software-fusion. The number of nodal metastases increased in five patients and decreased in four patients, leading to up-staging in one patient (2%) and down-staging in three patients (5%). In nine cases (15%), certainty and localization of metastases improved. However, the number of distant metastases did not change and software-fusion did not have an influence on resectability. CONCLUSION: PET/CT fusion substantially improves detection and localization of nodal metastases and may have an impact on locoregional treatment options.
Authors:
Liesbeth M Schreurs; Bareld B Pultrum; Klaas P Koopmans; Christian C Verhoef; Pieter L Jager; Gooitzen M Van Dam; Henk Groen; Erik J Van Der Jagt; John Th M Plukker
Related Documents :
20965393 - Contribution of positron emission tomography in pleural disease.
20364373 - Ability of 18f-fdg pet/ct to diagnose recurrent colorectal cancer in patients with elev...
1264883 - Radiologic examination of patients with stroke.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anticancer research     Volume:  28     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:    2008 May-Jun
Date Detail:
Created Date:  2008-07-17     Completed Date:  2008-07-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  1867-73     Citation Subset:  IM    
Affiliation:
Deparments of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Esophageal Neoplasms / pathology,  radionuclide imaging*
Female
Fluorine Radioisotopes / diagnostic use
Fluorodeoxyglucose F18 / diagnostic use
Humans
Lymph Nodes / pathology,  radionuclide imaging*
Lymphatic Metastasis
Male
Middle Aged
Neoplasm Staging
Positron-Emission Tomography / methods
Radiopharmaceuticals / diagnostic use
Retrospective Studies
Tomography, X-Ray Computed / methods
Chemical
Reg. No./Substance:
0/Fluorine Radioisotopes; 0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cancer chemoprevention: a summary of the current evidence.
Next Document:  The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic duct...